The significant enrichment of the “Cell cycle” pathway across these modules highlights the importance of CDK1 and CDC20 in NSCLC, as their dysregulation contributes to tumor aggressiveness and resistance to treatment [54]. This evidence concerns the gene CDC20 and non-small cell lung carcinoma.